Obestatin alleviates subarachnoid haemorrhage-induced oxidative injury in rats via its anti-apoptotic and antioxidant effects

Brain Injury

Volumn 27, Issue 10, 2013, Pages 1181-1189

  Erşahin, Mehmet ^a   Özsavci, Derya ^b   Şener, Azize ^b   Özakpinar, Özlem Bingöl ^b   Toklu, Hale Zerrin ^b   Akakin, Dilek ^c   Şener, Göksel ^b   Yeǧen, Berrak Ç ^d  

^a ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^b School of Pharmacy   (United Kingdom)

^c Western Campus of Tufts University   (United States)

^d MARMARA UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Obestatin; Oxidative; Stress; Subarachnoid haemorrhage

Indexed keywords

CASPASE 3; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; OBESTATIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN TISSUE; BRAIN WATER; CISTERNA MAGNA; CONTROLLED STUDY; EDEMA; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SUBARACHNOID HEMORRHAGE; WATER CONTENT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; BRAIN INJURIES; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PEPTIDE HORMONES; RATS; RATS, WISTAR; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84881443047     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2013.804199     Document Type: Article

References (70)

1. Oyama K, Criddle L. Vasospasm after aneurysmal subarachnoid hemorrhage. Critical Care Nurse 2004;24:58-60, 62, 64-67.
2. Ersahin M, Toklu HZ, Erzik C, Cetinel S, Akakin D, Velioglu-Ogunc A, Tetik S, Ozdemir ZN, Sener G, Yegen BC. The antiinflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats. Journal of Neurotrauma 2010;27:1143-1155.
3. Laskowitz DT, Kolls BJ. Neuroprotection in subarachnoid hemorrhage. Stroke 2010;41(Suppl 10):S79-84.
4. Yang Y, Zhang XJ, Yin J, Li LT. Brain damage related to hemorrhagic transformation following cerebral ischemia and the role of K ATP channels. Brain Research 2008;1241:168-175.
5. Germano A, d'Avella D, Cicciarello R, Hayes RL, Tomasello F. Blood-brain barrier permeability changes after experimental subarachnoid hemorrhage. Neurosurgery 1992;30:882-886.
6. Seckin H, Simsek S, Ozturk E, Yigitkanli K, Ozen O, Besalti O, Solaroglu I, Bavbek M. Topiramate attenuates hippocampal injury after experimental subarachnoid hemorrhage in rabbits. Neurological Research 2009;31:490-495.
7. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery 2003;53: 123-133; discussion 33-35.
8. Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: Historical overview, current treatment, and pathophysiology. World Neurosurgery 2010;73: 654-667.
9. Dietrich HH, Dacey Jr RG. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 2000;46:517-530. (Pubitemid 30146138)
10. Ansar S, Larsen C, Maddahi A, Edvinsson L. Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries. Brain Research 2010;1316: 163-172.
11. Ayer R, Zhang J. Connecting the early brain injury of aneurysmal subarachnoid hemorrhage to clinical practice. Turkish Neurosurgery 2010;20:159-166.
12. Asano T, Takakura K, Sano K, Kikuchi H, Nagai H, Saito I, Tamura A, Ochiai C, Sasaki T. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial. Journal of Neurosurgery 1996;84:792-803.
13. del Zoppo GJ, Hallenbeck JM. Advances in the vascular pathophysiology of ischemic stroke. Thrombosis Reserch 2000;98: 73-81.
14. Kozniewska E, Michalik R, Rafalowska J, Gadamski R, Walski M, Frontczak-Baniewicz M, Piotrowski P, Czernicki Z. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. Journal of Physiology & Pharmacology 2006;57:145-160. (Pubitemid 46569840)
15. Asano T. Oxyhemoglobin as the principal cause of cerebral vasospasm: A holistic view of its actions. Critical Reviews in Neurosurgery 1999;9:303-318.
16. Misra HP, Fridovich I. The generation of superoxide radical during the autoxidation of hemoglobin. Journal of Biological Chemistry 1972;247:6960-6962.
17. Ayer RE, Zhang JH. Oxidative stress in subarachnoid haemorrhage: Significance in acute brain injury and vasospasm. Acta Neurochirurgica Supplement 2008;104:33-41.
18. Kaptain GJ, Lanzino G, Kassell NF. Subarachnoid haemorrhage: Epidemiology, risk factors, and treatment options. Drugs & Aging 2000;17:183-199.
19. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005;310: 996-999. (Pubitemid 41611907)
20. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology & Metabolism 2002;87:2988-2991. (Pubitemid 34655375)
21. Gourcerol G, St-Pierre DH, Tache Y. Lack of obestatin effects on food intake: Should obestatin be renamed ghrelin-associated peptide (GAP)? Regulatory Peptides 2007;141:1-7. (Pubitemid 46505037)
22. Granata R, Settanni F, Gallo D, Trovato L, Biancone L, Cantaluppi V, Nano R, Annunziata M, Campiglia P, Arnoletti E, et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 2008;57: 967-979.
23. Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 2007;148: 148-159. (Pubitemid 46021447)
24. Liu Y, Wang PS, Xie D, Liu K, Chen L. Ghrelin reduces injury of hippocampal neurons in a rat model of cerebral ischemia/reperfusion. Chinese Journal of Physiology 2006;49:244-250.
25. Miao Y, Xia Q, Hou Z, Zheng Y, Pan H, Zhu S. Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochemical & Biophysical Research Communication 2007;359: 795-800. (Pubitemid 46899020)
26. Ersahin M, Toklu HZ, Erzik C, Akakin D, Tetik S, Sener G, Yegen BC. Ghrelin alleviates spinal cord injury in rats via its antiinflammatory effects. Turkish Neurosurgery 2011;21:599-605.
27. Szentirmai E, Krueger JM. Obestatin alters sleep in rats. Neuroscience Letters 2006;404:222-226. (Pubitemid 44063607)
28. Samson WK, White MM, Price C, Ferguson AV. Obestatin acts in brain to inhibit thirst. American Journal of Physiology-Regulatory Integrated and Comparative Physiology 2007;292: R637-643. (Pubitemid 46089880)
29. Carlini VP, Schioth HB, Debarioglio SR. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochemical & Biophysical Research Communication 2007;352: 907-912. (Pubitemid 44894371)
30. Delgado TJ, Brismar J, Svendgaard NA. Subarachnoid haemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 1985;16:595-602. (Pubitemid 15007231)
31. Toklu HZ, Uysal MK, Kabasakal L, Sirvanci S, Ercan F, Kaya M. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. Journal of Surgical Research 2009;152:238-248.
32. Mylroie AA, Collins H, Umbles C, Kyle J. Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicology & Applied Pharmacology 1986; 82:512-520. (Pubitemid 16162421)
33. Aebi H. Catalase in vitro. In: Bergmeyer HU, editor. Methods of enzymatic analysis, 2nd edn, Vol. 2. FL. 1974. p 121-126.
34. Beuge JA, Aust SD. Microsomal lipid peroxidation. In: Fleischer S, Packer I, editors. Methods in enzymology, Vol I, II, Academic Press, New York. 1978;52:302-311.
35. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine 1963;61:882-888.
36. Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. Journal of Pharmacology Methods 1990;24:285-295.
37. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 1990;186:464-478. (Pubitemid 20279989)
38. Diringer MN. Management of aneurysmal subarachnoid hemorrhage. Critical Care Medicine 2009;37:432-440.
39. Harrigan MR, Rajneesh KF, Ardelt AA, Fisher 3rd WS. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: Effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery 2010;67:935-939; discussion 9-40.
40. Stiebel-Kalish H, Turtel LS, Kupersmith MJ. The natural history of nontraumatic subarachnoid hemorrhage-related intraocular hemorrhages. Retina 2004;24:36-40. (Pubitemid 38240839)
41. Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage. Neurosurgery Clinics of North America 2010;21: 325-338.
42. Rothoerl RD, Finkenzeller T, Schubert T, Woertgen C, Brawanski A. High re-bleeding rate in young adults after subarachnoid haemorrhage from giant aneurysms. Neurosurgery Review 2006; 29:21-25. (Pubitemid 41677261)
43. Rabinstein AA, Pichelmann MA, Friedman JA, Piepgras DG, Nichols DA, McIver JI, Toussaint 3rd LG, McClelland RL, Fulgham JR, Meyer FB, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: A comparison between surgical repair and endovascular coil occlusion. Journal of Neurosurgery 2003;98:319-325. (Pubitemid 36151027)
44. Findlay JM, Deagle GM. Causes of morbidity and mortality following intracranial aneurysm rupture. Canadian Journal of Neurological Sciences 1998;25:209-215. (Pubitemid 28368796)
45. Cahill J, Calvert JW, Solaroglu I, Zhang JH. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage. Stroke 2006;37:1868-1874. (Pubitemid 44297744)
46. Sabri M, Kawashima A, Ai J, Macdonald RL. Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: A possible cause for poor prognosis. Brain Research 2008;1238:163-171.
47. Matz PG, Fujimura M, Lewen A, Morita-Fujimura Y, Chan PH. Increased cytochrome c-mediated DNA fragmentation and cell death in manganese-superoxide dismutase-deficient mice after exposure to subarachnoid hemolysate. Stroke 2001;32:506-515. (Pubitemid 32155243)
48. Meguro T, Chen B, Parent AD, Zhang JH. Caspase inhibitors attenuate oxyhemoglobin-induced apoptosis in endothelial cells. Stroke 2001;32:561-566. (Pubitemid 32155251)
49. Park S, Yamaguchi M, Zhou C, Calvert JW, Tang J, Zhang JH. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 2004;35:2412-2417. (Pubitemid 39311273)
50. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2006;26:1341-1353. (Pubitemid 44629883)
51. Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. Journal of Neurotrauma 2000;17:871-890.
52. Naoi M, Maruyama W, Shamoto-Nagai M, Yi H, Akao Y, Tanaka M. Oxidative stress in mitochondria: Decision to survival and death of neurons in neurodegenerative disorders. Molecular Neurobiology 2005;31:81-93. (Pubitemid 41271195)
53. Sen O, Caner H, Aydin MV, Ozen O, Atalay B, Altinors N, Bavbek M. The effect of mexiletine on the level of lipid peroxidation and apoptosis of endothelium following experimental subarachnoid hemorrhage. Neurological Research 2006;28:859-863. (Pubitemid 44904463)
54. Dong J, Song N, Xie J, Jiang H. Ghrelin antagonized 1-methyl-4- phenylpyridinium (MPP(?))-induced apoptosis in MES23.5 cells. Journal of Molecular Neuroscience 2009;37:182-189.
55. Wang G, Wang W, Zhao J, Ni Y, Zhou X, Zhang W. Ghrelin prevents neuronal apoptosis and cognitive impairments in sepsisassociated encephalopathy. Neuroreport 2011;22:959-964.
56. Feng DD, Yang SK, Loudes C, Simon A, Al-Sarraf T, Culler M, Alvear-Perez R, Llorens-Cortes C, Chen C, Epelbaum J, et al. Ghrelin and obestatin modulate growth hormone-releasing hormone release and synaptic inputs onto growth hormone-releasing hormone neurons. European Journal of Neurosciences 2011;34: 732-744.
57. Pan W, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides: Obestatin, ghrelin, and adiponectin. Peptides 2006;27:911-916.
58. Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, Alexandrovich A, Shohami E. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiology of Disease 2006;22:257-264.
59. Belayev L, Busto R, Zhao W, Ginsberg MD. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Reserch 1996;739:88-96. (Pubitemid 26387366)
60. Doczi T, Joo F, Adam G, Bozoky B, Szerdahelyi P. Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery 1986;18: 733-739. (Pubitemid 16067827)
61. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends in Neuroscience 2001;24:719-725. (Pubitemid 33097539)
62. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Japanese Journal of Pharmacology 2002;88:227-249. (Pubitemid 34302973)
63. Ozsavci D, Ersahin M, Sener A, Ozakpinar OB, Toklu HZ, Akakin D, Sener G, Yegen BC. The novel function of nesfatin-1 as an antiinflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery 2011; 68:1699-1708; discussion 1708.
64. Jedrzejowska-Szypulka H, Straszak G, Larysz-Brysz M, Karpe J, Marcol W, Olakowska E, Woszczycka-Korczynska I, Lewin-Kowalik J. Interleukin-1beta plays a role in the activation of peripheral leukocytes after blood-brain barrier rupture in the course of subarachnoid hemorrhage. Current Neurovascular Research 2010;7:39-48.
65. Gaetani P, Lombardi D. Brain damage following subarachnoid hemorrhage: The imbalance between anti-oxidant systems and lipid peroxidative processes. Journal of Neurosurgical Sciences 1992;36: 1-10.
66. Serrano F, Kolluri NS, Wientjes FB, Card JP, Klann E. NADPH oxidase immunoreactivity in the mouse brain. Brain Research 2003; 988:193-198. (Pubitemid 37289510)
67. El Eter E, Al Tuwaijiri A, Hagar H, Arafa M. In vivo and in vitro antioxidant activity of ghrelin: Attenuation of gastric ischemic injury in the rat. Journal of Gastroenterology and Hepatology 2007; 22:1791-1799. (Pubitemid 47525067)
68. Obay BD, Tasdemir E, Tumer C, Bilgin HM, Atmaca M. Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Peptides 2008;29:448-455.
69. Moon M, Choi JG, Nam DW, Hong HS, Choi YJ, Oh MS, Mook-Jung I. Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice. Journal of Alzheimers Disease 2011;23:147-159.
70. Ma LY, Zhang DM, Tang Y, Lu Y, Zhang Y, Gao Y, Xia L, Zhao KX, Chai LY, Xiao Q. Ghrelin-attenuated cognitive dysfunction in streptozotocin-induced diabetic rats. Alzheimer Disease & Associated Disorders 2011;25:352-363.